120 related articles for article (PubMed ID: 2455210)
1. Amphetamine-induced in vivo release of dopamine in the striatum is influenced by local pH.
Guan XM; McBride WJ
Life Sci; 1988; 42(25):2625-31. PubMed ID: 2455210
[TBL] [Abstract][Full Text] [Related]
2. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):179-92. PubMed ID: 3007736
[TBL] [Abstract][Full Text] [Related]
3. Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the presence of vesicular transmitter stores.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1986 Apr; 237(1):193-203. PubMed ID: 3007738
[TBL] [Abstract][Full Text] [Related]
4. The effects of pH on amphetamine-induced dopamine release as measured by in vivo dialysis.
Thomas DN; Holman RB
Life Sci; 1989; 45(14):1299-305. PubMed ID: 2478856
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
6. Effects of K+-stimulation and precursor loading on the in vivo release of dopamine, serotonin and their metabolites in the nucleus accumbens of the rat.
Guan XM; McBride WJ
Life Sci; 1987 Jun; 40(26):2579-86. PubMed ID: 2439863
[TBL] [Abstract][Full Text] [Related]
7. In vivo basal and amphetamine-induced striatal dopamine and metabolite levels are similar in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male rats.
Ferguson SA; Gough BJ; Cada AM
Physiol Behav; 2003 Oct; 80(1):109-14. PubMed ID: 14568315
[TBL] [Abstract][Full Text] [Related]
8. Seizure activity and hyperthermia potentiate the increases in dopamine and serotonin extracellular levels in the amygdala during exposure to d-amphetamine.
Tor-Agbidye J; Yamamoto B; Bowyer JF
Toxicol Sci; 2001 Mar; 60(1):103-11. PubMed ID: 11222877
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.
Parker EM; Cubeddu LX
J Pharmacol Exp Ther; 1988 Apr; 245(1):199-210. PubMed ID: 3129549
[TBL] [Abstract][Full Text] [Related]
10. The release of endogenous dopamine and its metabolites from rat striatum as detected in push-pull perfusates: effects of systematically administered drugs.
Radhakishun FS; Korf J; Venema K; Westerink BH
Pharm Weekbl Sci; 1983 Aug; 5(4):153-8. PubMed ID: 6622209
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine and mCPP effects on dopamine and serotonin striatal in vivo microdialysates in an animal model of hyperactivity.
Nowak P; Bortel A; Dabrowska J; Oswiecimska J; Drosik M; Kwiecinski A; Opara J; Kostrzewa RM; Brus R
Neurotox Res; 2007 Feb; 11(2):131-44. PubMed ID: 17449455
[TBL] [Abstract][Full Text] [Related]
12. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats.
Gerhardt GA; Maloney RE
Brain Res; 1999 Jan; 816(1):68-77. PubMed ID: 9878690
[TBL] [Abstract][Full Text] [Related]
13. d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites.
De Deurwaerdère P; Bonhomme N; Le Moal M; Spampinato U
J Neurochem; 1995 Sep; 65(3):1100-8. PubMed ID: 7543929
[TBL] [Abstract][Full Text] [Related]
14. Release of endogenous dopamine, 3,4-dihydroxyphenylacetic acid, and amino acid transmitters from rat striatal slices.
Flint RS; Murphy JM; McBride WJ
Neurochem Res; 1985 Apr; 10(4):515-27. PubMed ID: 2860579
[TBL] [Abstract][Full Text] [Related]
15. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
16. Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis study.
Feigenbaum JJ; Howard SG
Life Sci; 1997; 60(19):1659-68. PubMed ID: 9129121
[TBL] [Abstract][Full Text] [Related]
17. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
Ichikawa J; Meltzer HY
Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
[TBL] [Abstract][Full Text] [Related]
18. Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.
Miller HH; Shore PA
Eur J Pharmacol; 1982 Feb; 78(1):33-44. PubMed ID: 6122585
[TBL] [Abstract][Full Text] [Related]
19. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis.
Kuczenski R; Segal D
J Neurosci; 1989 Jun; 9(6):2051-65. PubMed ID: 2566664
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.
Robinson TE; Camp DM
Pharmacol Biochem Behav; 1987 Apr; 26(4):821-7. PubMed ID: 2440058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
